False Claims Act prosecution did not deter off-label drug use in the case of neurontin. (Q34238913)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | False Claims Act prosecution did not deter off-label drug use in the case of neurontin. |
scientific article |
Statements
False Claims Act prosecution did not deter off-label drug use in the case of neurontin (English)
Robert Glynn
Jerry Avorn
David M Studdert